IMPORTANT SAFETY INFORMATION
Do not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.
Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:
- Have high blood pressure
- Have circulation problems in your fingers and toes
- Have liver problems
- Have kidney problems
- Are pregnant or plan to become pregnant
- Are breastfeeding or plan to breastfeed
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
UBRELVY may cause serious side effects, including:
- Allergic reactions: Most reactions happened within hours after taking UBRELVY and were not serious. Some reactions may occur days after taking UBRELVY. Call your healthcare provider or get emergency help right away if you have swelling of the face, mouth, tongue, or throat or trouble breathing.
- High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure.
- Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur.
The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
What is UBRELVY® (ubrogepant)?
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
US-UBR-250100
Please see full Patient Information.
SPEAK TO A DOCTOR ONLINE AND FIND OUT IF UBRELVY IS RIGHT FOR YOU
Use telemedicine to connect to a doctor. Here's how:
Answer a few simple questions about your migraine attacks and current treatment plan.
Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.
If a prescription is written, you can pick it up at a local pharmacy you choose.
AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0* A MONTH FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.
*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly and annual maximums, may apply. This is not health insurance. For full Terms, Conditions, and Eligibility Criteria, visit UBRELVY.com/savings-terms. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.
By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.
SPEAK TO A DOCTOR ONLINE AND FIND OUT IF UBRELVY IS RIGHT FOR YOU
Use telemedicine to connect to a doctor. Here's how:
Answer a few simple questions about your migraine attacks and current treatment plan.
Connect directly to a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript.
If a prescription is written, you can pick it up at a local pharmacy you choose.
AS A REMINDER, YOU MAY BE ELIGIBLE TO PAY AS LITTLE AS $0* A MONTH FOR YOUR UBRELVY PRESCRIPTION. TEXT UBRELVY TO 48764† TO GET STARTED.
*Eligibility: Available to patients with commercial insurance coverage for UBRELVY who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly and annual maximums, may apply. This is not health insurance. For full Terms, Conditions, and Eligibility Criteria, visit UBRELVY.com/savings-terms. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy.
†Msg & data rates may apply. You are not required to consent as a condition of receiving goods or services. You can reply HELP for help. You can reply STOP to opt out at any time. By texting UBRELVY to 48764, you agree to AbbVie's Mobile T&C at https://abbv.ie/USMobileTerms and Privacy Notice at https://abbv.ie/corpprivacy. Full Prescribing Information available at https://www.rxabbvie.com/pdf/ubrelvy_pi.pdf.
UpScript‡, one of many telemedicine platforms, lets you speak with a healthcare provider to see if UBRELVY is right for you, all from the comfort of your own home.
‡Third-party website; does not constitute an endorsement or recommendation by AbbVie.
By clicking “Talk Now” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “talk now” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on UBRELVY.com.
US-UBR-250117